4//SEC Filing
Shaffer James P 4
Accession 0001209191-19-021285
CIK 0001305253other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 10:12 AM ET
Size
17.1 KB
Accession
0001209191-19-021285
Insider Transaction Report
Form 4
Shaffer James P
Chief Business Officer
Transactions
- Award
Common Stock
2017-09-05$9.90/sh+1,500$14,854→ 8,421 total - Award
Common Stock
2019-03-05$7.95/sh+1,500$11,921→ 12,921 total - Award
Common Stock
2017-03-06$8.20/sh+1,301$10,671→ 6,921 total - Award
Common Stock
2018-03-05$8.03/sh+1,500$12,049→ 9,921 total - Award
Common Stock
2018-09-05$7.95/sh+1,500$11,921→ 11,421 total - Award
Stock Option ( Right to Buy)
2019-03-21+50,000→ 50,000 totalExercise: $14.31Exp: 2029-03-20→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Includes shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The option vests in equal monthly installments over 48 months measured from March 21, 2019 subject to Reporting Person's continuous service status as of each such date.
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001488919
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 10:12 AM ET
- Size
- 17.1 KB